The research, led by Wenling Ye, Yang Zhao, and Fengling Wang under the direction of corresponding authors Wei-Dong Chen and Yan-Dong Wang, focused on the farnesoid X receptor, or FXR, a ligand-activated transcription factor expressed abundantly in the liver and intestine. FXR has long been recognized as a master regulator of bile acid homeostasis, lipid metabolism, and glucose control, and several FXR agonists have already entered clinical development for cholestatic liver disease and non-alcoholic steatohepatitis. The new work adds an unexpected dimension to this receptor’s portfolio: it appears to govern how the liver rebuilds its resident population of macrophages, the Kupffer cells, after surgical injury.

Kupffer cells are the liver’s resident sentinels, embedded in the sinusoidal blood vessels that perfuse the organ. They clear circulating debris and pathogens, but during regeneration they do something equally important: they broadcast the inflammatory and growth-promoting signals that push hepatocytes out of their quiescent state and into the cell cycle. Because these cells are consumed and reprogrammed as regeneration proceeds, the liver must continuously replenish its Kupffer cell pool from two sources. The first is local, the proliferation of resident Kupffer cells that survived the initial insult. The second is systemic, the recruitment of monocytes circulating in the bloodstream, which home to the injured liver and differentiate into macrophage-like cells that can take up residence there.

To test whether FXR controls this replenishment program, the team used a mouse model of two-thirds partial hepatectomy, the standard experimental system for studying liver regeneration. In wild-type mice, the regenerating lobes showed robust activation of both T cells and Kupffer cells, with increased infiltration of these immune populations into the remnant tissue, exactly the kind of coordinated immune response that regeneration theory predicts. The picture in mice lacking FXR was strikingly different. Although these animals started with elevated baseline numbers of both T cells and Kupffer cells in their livers, once surgery removed two-thirds of the organ, their regenerating livers displayed markedly attenuated immune activation and reduced immune cell infiltration compared with normal mice.

The consequence was a measurable delay in regeneration. The researchers traced this defect to failures in both arms of the Kupffer cell replenishment pathway. In FXR-deficient mice, circulating monocytes were less able to migrate into the regenerating liver, starving the organ of fresh macrophage precursors. At the same time, the resident Kupffer cells that remained proliferated poorly, so the local self-renewal route was also compromised. With both supply lines disrupted, the Kupffer cell pool failed to recover its normal size and composition, and the polarization balance between classically activated M1 macrophages and alternatively activated M2 macrophages was altered, further disturbing the cytokine environment that regenerating hepatocytes require.

Mechanistically, the study identified two molecular pathways through which FXR exerts this control. The first operates on monocyte trafficking. FXR, acting as a transcription factor, directly targets the gene encoding CCR2, the chemokine receptor that serves as the homing beacon for inflammatory monocytes. CCR2 allows circulating monocytes to sense chemokines released by injured tissue and migrate along the gradient toward the wound. By promoting CCR2 expression, FXR effectively keeps the recruitment pipeline open during regeneration. When FXR is absent, this beacon dims, monocytes fail to arrive in sufficient numbers, and the liver loses its most important source of replacement macrophages.

The second pathway governs local proliferation. The researchers found that FXR enhances the expansion of resident Kupffer cells through the CSF1/PI3K/Akt signaling cascade. Colony-stimulating factor 1, or CSF1, is the essential survival and growth factor for cells of the mononuclear phagocyte lineage, and signaling through its receptor activates phosphoinositide 3-kinase and the Akt kinase, a canonical pathway that drives cell growth, survival, and division. By potentiating this cascade in Kupffer cells, FXR ensures that the resident population can double and repopulate the regenerating tissue. The two mechanisms work synergistically: one replenishes the pool from the blood, the other from within, and together they restore Kupffer cell homeostasis at the pace that regeneration demands.

The study also offers a possible explanation for a clinical observation that has long frustrated transplant surgeons and hepatologists: regenerative capacity declines with age. In aged mice, the researchers observed impaired monocyte recruitment to the regenerating liver, mirroring the defect seen in FXR-deficient animals. If the same age-related erosion of the FXR-monocyte axis occurs in humans, it could help explain why elderly patients recover more slowly from major hepatic resection and why organs from older donors regenerate less vigorously after transplantation. This finding reframes aging of the liver not simply as a decline in hepatocyte proliferative potential but as a failure of the immune support system that scaffolds that proliferation.

The clinical implications are considerable. Liver transplantation and partial hepatectomy remain the most effective therapies for end-stage liver disease, yet the persistent shortage of donor organs has intensified interest in interventions that could enhance regeneration, expand the pool of usable grafts, and improve post-surgical outcomes. The identification of the FXR-Kupffer cell axis as a central regulator of liver repair suggests a concrete therapeutic target. Small-molecule FXR agonists, several of which are already approved or in late-stage clinical trials for other liver conditions, could in principle be repurposed or optimized to boost monocyte recruitment and Kupffer cell expansion in patients undergoing hepatic resection or receiving partial grafts from living donors.

As with any mouse study, important questions remain before these findings can be translated. The work was conducted in genetically engineered mice lacking FXR entirely, and the timing, dose, and cell-type specificity of any future pharmacological intervention will need careful optimization. It will also be essential to determine whether activating FXR in humans produces the same immune cell effects without exacerbating the inflammatory components of chronic liver disease, since macrophage polarization is a double-edged sword in conditions such as fibrosis and cirrhosis. Nevertheless, by connecting a well-characterized metabolic receptor to the cellular logistics of immune replenishment, the study adds a compelling new layer to the biology of liver regeneration. It suggests that the liver’s famous ability to rebuild itself rests not only on the proliferative drive of its hepatocytes but on a receptor-controlled program that recruits, renews, and reactivates the macrophages those hepatocytes depend on, and that keeping this program running may one day mean the difference between a graft that thrives and one that fails.

Subject of Research: FXR regulation of Kupffer cell pool restoration during liver regeneration

Article Title: An FXR-dependent cellular program for Kupffer cell pool restoration fuels liver regeneration

Article References: Ye, W., Zhao, Y., Wang, F., Wang, Y., Qu, Y., Li, Y., Wang, Y.-D., & Chen, W.-D. (2026). An FXR-dependent cellular program for Kupffer cell pool restoration fuels liver regeneration. Cell Death Discovery. https://doi.org/10.1038/s41420-026-03398-z

Image Credits: AI Generated

DOI: 10.1038/s41420-026-03398-z

Keywords: liver regeneration, FXR, Kupffer cells, monocyte recruitment, CCR2, CSF1, PI3K/Akt signaling, partial hepatectomy, macrophage polarization, liver transplantation, aging, nuclear receptor

Tenosynovial giant cell tumor, or TGCT, is a neoplasm arising from the synovial lining of joints, bursae, or tendon sheaths. Under the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours, the disease is divided by growth pattern into localized and diffuse types. The diffuse variant, historically known as pigmented villonodular synovitis, is a locally aggressive lesion marked by extensive synovial proliferation, nodular growth, and a strong tendency to recur. It most often strikes the knee, but also appears in the finger, ankle, and shoulder. Hip involvement is uncommon, and that rarity is precisely what makes it so dangerous diagnostically: when a deep, inaccessible joint begins to erode bone, the list of possible culprits is long and includes some far more alarming possibilities.

The patient’s story began one week before admission, when he experienced acute chills and high fever and received three days of empirical intravenous cefuroxime at a local hospital, with partial improvement. Then came the hip pain — acute, severe, worst at night, disturbing his sleep, and worsened by movement. Rest and repositioning did not help. On examination he was afebrile at 36.4°C, with marked tenderness over the right hip, pain provoked by internal rotation, adduction, and flexion, and mildly restricted range of motion. There was no redness, warmth, or swelling, no trauma, no weight loss, and no evening fevers. The distal neurovascular examination was unremarkable. In short, nothing about the physical presentation clearly separated infection from tumor.

Imaging told a more revealing story, though not a definitive one. Magnetic resonance imaging of both hips demonstrated abnormal intra-articular synovial tissue in the right hip, with mild bilateral joint effusion that was more pronounced on the right. The lesion, measuring approximately 27 by 35 by 25 millimeters, showed heterogeneous low-to-intermediate signal intensity on T1-weighted images, heterogeneous signal on T2-weighted images, and heterogeneous enhancement after contrast administration — a signal profile characteristic of TGCT, reflecting variable proportions of fibrous tissue, lipid-laden macrophages, fluid, and hemosiderin deposition. The adjacent anterior acetabular column appeared thinned, and mild swelling of the right obturator externus muscle was noted. Computed tomography then showed joint effusion, cystic low-density intra-articular lesions, and clear thinning and erosion of the anterior and inferomedial acetabular wall. Notably, the plain radiograph showed no definite abnormality, underscoring why advanced imaging is essential when plain films fail.

Laboratory testing deepened the ambiguity rather than resolving it. The white blood cell count was 6.46 × 10⁹/L with 68.4% neutrophils, C-reactive protein was elevated at 34.20 mg/L, the erythrocyte sedimentation rate was 25 mm/h, and procalcitonin measured 0.268 ng/mL — a pattern suggestive of low-grade inflammation but far from conclusive. Serum alkaline phosphatase and tumor markers were normal. Whole-body bone scintigraphy showed increased tracer uptake in both hips, sacroiliac joints, and shoulders, which clinicians judged most consistent with degenerative change. With a recent febrile illness, equivocal inflammatory markers, and a destructive-appearing acetabular lesion, the preoperative differential diagnosis spanned infectious or inflammatory synovitis, synovial chondromatosis, and other aggressive synovial or osseous lesions. Because neither imaging nor laboratory work could deliver a verdict, the team proceeded to surgical exploration after multidisciplinary discussion.

What surgeons found inside the joint settled the immediate uncertainty about the lesion’s nature while illustrating why preoperative diagnosis is so difficult. Intraoperative inspection revealed abundant yellowish joint fluid and diffuse proliferation of synovium-like tissue throughout the right hip, with irregular nodular lesions along the anteromedial and inferomedial acetabular wall. The team performed complete excision of the identified intra-articular lesions and involved synovial tissue, curetted the eroded inferomedial acetabular wall, treated it with alcohol ablation, and reconstructed the localized bone defect with an autologous iliac bone graft. Estimated blood loss was approximately 150 milliliters. Although the lesion contained nodular components measuring up to roughly 1.5 by 3.0 centimeters, it was classified as diffuse-type TGCT because of the widespread intra-articular synovial involvement, the acetabular erosion, and the absence of a solitary encapsulated mass.

Histopathologic examination provided the gold-standard confirmation. Microscopy showed proliferative synovium-like tissue with focal cyst wall-like structures lined by flattened to cuboidal cells, a stroma containing proliferative fibrous tissue, histiocytes, prominent congested vessels, diffuse chronic inflammatory cells, scattered neutrophils, and focal coagulative necrosis. Scattered and clustered foamy histiocytes and variable numbers of osteoclast-like multinucleated giant cells were present, along with hemosiderin granules within the cytoplasm of mononuclear cells and histiocytes — the pigment that gave the old disease its name. Immunohistochemistry showed strong CD68 positivity in the multinucleated giant cells and a subset of mononuclear cells, focal S-100 expression, and a Ki-67 labeling index of approximately 5% to 10%, compatible with low proliferative activity. Focal coagulative necrosis was interpreted as a secondary degenerative or ischemic change, and no cytologic atypia, atypical mitotic activity, or sarcomatous overgrowth was identified. Joint-fluid cultures were negative for bacterial and fungal growth, though the authors caution that prior cefuroxime exposure may have reduced culture sensitivity, so infection could never be excluded on microbiologic grounds alone.

The molecular backdrop of this tumor is one of the more fascinating chapters in modern soft-tissue oncology. TGCT is associated with overexpression of colony-stimulating factor 1, or CSF1, which recruits macrophages to the lesion through what researchers call the landscape effect — a minority population of neoplastic cells orchestrating a massive influx of reactive, non-neoplastic immune cells that constitute most of the tumor’s bulk. This mechanism also underpins CSF1/CSF1R-targeted therapies, which are reserved for selected patients with residual, recurrent, or incompletely resectable disease. In this case, however, gross excision and synovectomy were achieved without postoperative radiotherapy or systemic antitumor therapy, with management transitioning instead to clinical and imaging surveillance.

The recovery course was largely favorable, punctuated by one unrelated complication. The patient experienced marked pain relief immediately after surgery, but on postoperative day three he developed fever, mild cough, and fatigue. Chest CT revealed bilateral patchy opacities, pulmonary infection was diagnosed, and intravenous cefuroxime with supportive care normalized his temperature and resolved his systemic symptoms. Follow-up imaging told a reassuring story: CT on the first postoperative day showed satisfactory filling of the acetabular defect by the bone graft, and at two months the graft maintained its position with osseous incorporation and healing. At the two-week mark the incision was well healed and hip motion had improved beyond preoperative levels. By six months, the patient reported sustained pain improvement and had returned to independent daily activities and work, although mild limitation of right hip motion persisted.

The case, reported in Cancer Reports, carries an educational message that resonates well beyond a single patient. Because the hip joint is deeply situated and its capsule has limited capacity to accommodate proliferative synovium, osseous erosion is a recognized feature of hip D-TGCT — yet a destructive-appearing acetabular lesion inevitably raises concern for septic arthritis, inflammatory synovitis, synovial chondromatosis, or a more aggressive neoplasm. The authors emphasize that MRI remains the preferred modality for mapping the extent of synovial disease, while CT more clearly delineates the osseous erosion relevant to operative planning, making the two techniques complementary rather than interchangeable. Ultimately, imaging alone could not reliably distinguish this tumor from infectious or aggressive etiologies; definitive diagnosis depended on integrating the clinical course, intraoperative observations, and characteristic histopathologic features. The authors frame the report primarily as an educational account of diagnostic evaluation and multidisciplinary management rather than evidence of durable local control, noting that the follow-up period remains short and that recurrence is a recognized concern given the complex anatomy of the hip. Longer surveillance will be needed to assess recurrence, joint function, and treatment durability. The broader lesson stands: diffuse-type tenosynovial giant cell tumor deserves a place on the differential diagnosis of any unexplained erosive intra-articular hip lesion, even when the clinical context screams infection.

Subject of Research: Diffuse-type tenosynovial giant cell tumor of the hip with acetabular bone involvement diagnosed by radiologic-pathologic correlation.

Article Title: Diffuse‐Type Tenosynovial Giant Cell Tumor of the Hip With Acetabular Bone Involvement: A Case Report With Radiologic‐Pathologic Correlation

Article References: Quanbing, W., Huanhuan, X., Xing, Z., Tao, Y., Jun, Z., Lei, Z., Kai, L., Lei, L., Feng, A., & Wei, Y. (2026). Diffuse‐Type Tenosynovial Giant Cell Tumor of the Hip With Acetabular Bone Involvement: A Case Report With Radiologic‐Pathologic Correlation. Cancer Reports, 9(9), Article e70696. https://doi.org/10.1002/cnr2.70696

Image Credits: AI Generated

DOI: 10.1002/cnr2.70696

Keywords: tenosynovial giant cell tumor, diffuse-type TGCT, hip, acetabular erosion, MRI, CT, synovectomy, histopathology, CSF1, case report, orthopedic oncology, diagnostic imaging